Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2026-02-25 @ 11:48 PM
Study NCT ID:
NCT05460832
Status:
COMPLETED
Last Update Posted:
2025-04-24
First Post:
2022-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA
Sponsor:
Modern Biosciences Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-12
First Submit QC Date:
None
Study First Post Date:
2022-07-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-28
Results First Submit QC Date:
None
Results First Post Date:
2025-04-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-07
Last Update Post Date:
2025-04-24
Last Update Post Date Type:
ACTUAL